Circadian regulation of renal function and potential role in hypertension. by Bonny, O. & Firsov, D.
 1 
Circadian regulation of renal function and potential role in hypertension. 
 
Olivier Bonny1,2#  and Dmitri Firsov1# 
 
1 - Department of Pharmacology and Toxicology, University of Lausanne, Switzerland 
2 - Service of Nephrology, Department of Medicine, CHUV, Lausanne, Switzerland  
 
#  - to whom correspondence should be addressed: 
 
Dmitri Firsov,  Department of Pharmacology and Toxicology, University of Lausanne, 27 rue 
du Bugnon, 1005 Lausanne, Switzerland. e-mail: dmitri.firsov@unil.ch 
Phone:  ++41216925406 
and 
Olivier Bonny, Department of Pharmacology and Toxicology, University of Lausanne, 27 rue 
du Bugnon, 1005 Lausanne, Switzerland. e-mail: olivier.bonny@unil.ch 
Phone:  ++41216925417 
 
The authors have declared that no conflict of interest exists. 
 
Key points: 1. The circadian clock controls a large number of specific renal functions. 2. The 
circadian clock is involved in renal sodium handling through a variety of recently elucidated 
mechanisms. 3. Alteration of circadian rhythms in humans is associated with several 
conditions, including decreased glucose sensitivity, hypertension and cancer. 4. 
Chronopharmacotherapy is an emerging field that may help treating conditions like 
hypertension and cancer. 
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Purpose of review: Previous studies have shown that a variety of specific renal functions 
exhibit circadian oscillations. This review aims (i) to provide an update on the molecular 
mechanisms underlying circadian rhythms in the kidney, and (ii) to discuss how dysregulation 
of circadian rhythms can interfere with kidney function. 
Recent findings:  The molecular mechanism responsible for generating and maintaining 
circadian rhythms has been unraveled in great detail. This mechanism, known as circadian 
clock, drives circadian oscillation in expression levels of a large number of renal mRNA 
transcripts. Several proteins critically involved in renal homeostatic functions have been 
shown to exhibit significant circadian oscillation in their expression levels or in their 
posttranslational modifications. In transgenic mouse models, disruption of circadian clock 
activity results in dramatic changes in the circadian pattern of urinary sodium and potassium 
excretion and causes significant changes in arterial blood pressure. A growing number of 
evidence suggests that dysregulation of circadian rhythms is associated with the development 
of hypertension and accelerated progression of chronic kidney disease (CKD) and 
cardiovascular disease in humans. Chronotherapy studies have shown that the efficacy of 
antihypertensive medication is greatly dependent on the circadian time of drug administration.  
Summary: Recent research points to the major role of circadian rhythms in renal function and 
in control of blood pressure. 
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Introduction 
Circadian rhythmicity of renal function is a long-studied phenomenon which was first 
documented in the middle of the 19th century when Edward Smith and other pioneers in 
chronobiology noted that urinary water and urea excretion exhibit significant circadian 
oscillations [1]. The existence of circadian rhythms was subsequently revealed in a number of 
specific renal functions. Despite the apparent correlation of renal circadian rhythms with 
rhythms of activity and feeding, physiological studies demonstrated that several important 
rhythmic processes in the kidney (e.g. circadian rhythm of urinary potassium excretion) are 
largely self-sustained and intrinsic in origin (reviewed in [2,3]). On the molecular level, it has 
been shown that circadian rhythms are primarily driven by the circadian clock, a complex 
mechanism that tightly coordinates all major cellular functions with the time of the 24-hour 
geophysical cycle (circadian time). This coordination provides an important functional 
advantage which consists in time-of-day-dependent preconditioning of cells and organs to 
recurrent environmental circadian changes. 
  Long-term misalignment of intrinsic circadian rhythms with environmental time has 
been shown as an independent risk factor for the progression of a variety of diseases, 
including diabetes, cardiovascular disease, chronic kidney disease and cancer (reviewed in 
[4,5]). Genome Wide Association Studies (GWAS) have suggested a genetic link between 
single nucleotide polymorphisms (SNPs) in genes involved in the circadian clock and type 2 
diabetes [6], hypertension [7] and mood disorders [8]. A growing number of mouse models in 
which the activity of the circadian clock was modified have demonstrated that this mechanism 
is indispensable for many vital processes, including renal homeostatic function and blood 
pressure control. In this review we summarize advances achieved within the last 12-18 
months in the understanding of the role of the circadian timing system in kidney health and 
disease. 
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The circadian clock  Recent research has revealed that circadian rhythms are driven 
by a highly complex mechanism operating at different molecular levels. The first discovered 
and most studied circadian clock mechanism involves the transcriptional factors BMAL1, 
CLOCK and NPAS2 and their repressors PER and CRY (reviewed in [**9]). These proteins 
constitute the core of a transcriptional/translational feedback loop that generates 
transcriptional rhythms with a periodicity of ∼24 hours. The BMAL1/CLOCK or 
BMAL1/NPAS2 heterodimers activate transcription and translation of PER and CRY during 
the daytime. Accumulation of PER and CRY proteins in the cytoplasm results in their 
heterodimerization and translocation into the nucleus where PER/CRY complexes bind to and 
inhibit the transcriptional activity of BMAL1/CLOCK and BMAL1/NPAS2. In the absence of 
de novo synthesis, PER and CRY are progressively depleted during the night by the 
ubiquitination/proteosome degradation pathway, thus resulting in the relief of the 
transcriptional repression (so completing the 24-hour cycle). Activity of this circadian clock 
in peripheral tissues is largely self-sustained and cell-autonomous, but its synchronization 
with the environmental time is dependent on a central pacemaker located in the 
suprachiasmatic nucleus of hypothalamus. In addition to the regulation of PER and CRY 
transcription, the BMAL1/CLOCK and BMAL1/NPAS2 heterodimers are thought to generate 
circadian oscillations of 2-10% of cellular transcriptome. For instance, Zuber et al. have 
shown that hundreds of mRNA transcripts in the microdissected distal convoluted tubule 
(DCT), connecting tubule (CNT) and cortical collecting duct (CCD) exhibit significant 
circadian oscillations, and Nikolaeva et al. have demonstrated that circadian rhythmicity of 
many of these transcripts is abolished in mice devoid of CLOCK [10,**11]. Many among the 
oscillating transcripts are crucially involved in different homeostatic renal functions e.g., 
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aquaporin 2- and 4- water channels, the V2 vasopressin receptor, the NHE3 sodium proton 
exchanger, serum- and glucocorticoid- induced kinase 1 (Sgk1), the H,K-ATPase type 2 and 
the regulator of the Na,K-ATPase Fxyd5 [10,12,*13,14].  
 This classical model of the circadian clock based on the transcriptional oscillations has 
been seriously challenged by several recent studies. Menet et al. and Koike et al. have shown 
that oscillations of only about 20% of mature circadian mRNAs result from the circadian 
transcription [15,**16]. These studies pointed to the very important role of posttranscriptional 
events in the generation of circadian transcriptome. Another level of complexity in the 
circadian clock was revealed by the discovery of so-called “metaclocks” involving anti-
oxidant proteins peroxiredoxins (PRX). PRXs exhibit transcription-independent oscillations 
in their oxidation states that parallel circadian production of reactive oxygen species (ROS) in 
mitochondria. Importantly, Edgar et al. have shown that the PRX oxidation state can influence 
the circadian transcriptional component, thereby demonstrating the interconnectivity between 
different circadian mechanisms [*17]. Finally, Jouffe et al. have recently demonstrated that 
the circadian clock controls ribosome biogenesis, a mechanism which is thought to be 
involved in the dynamic regulation of energy homeostasis in the cell [18]. 
Circadian rhythms in the kidney Accumulating evidence suggests that most if not all 
specific renal functions exhibit circadian oscillations. For instance, many renal rhythms are 
imposed by the circadian rhythmicity in the glomerular filtration rate (GFR), the renal blood 
flow (RBF) and the plasma concentration of filtered solutes. As an example, both the GFR 
and the plasma concentration of amino acids rise by ∼50% during the activity phase of the 
circadian cycle, thereby generating significant circadian oscillations in the filtered load of 
amino acids (cumulative amplitude of ∼100%) [19]. This, in turn, imposes a requirement for 
circadian adaptation in the reabsorption capacity for amino acids in the proximal tubule. How 
does this adaptation occurs at the molecular level has not been investigated, but our analyses 
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of renal circadian transcriptomes has shown that several major apical and basolateral 
transporters of amino acids exhibit significant circadian oscillations in their mRNA 
expression levels (Figure 1). A similar rationale can be applied to a wide variety of filtered 
substances since Dallmann et al. and Eckel-Mahan et al. have recently shown that at least 
15% of blood metabolites cycle with a 24-hour rhythmicity (this rationale is depicted in 
Figure 2) [*20,*21].  
 Previous functional studies have suggested that the circadian clock is involved in 
blood pressure control. For instance, Bankir et al. demonstrated that the circadian dynamic of 
urinary sodium excretion is an important determinant of dipping in nocturnal blood pressure 
[22]. The discovery of the clock genes has allowed a direct assessment of the role of the 
circadian clock in renal function and in blood pressure control. Woon et al. have identified 
several polymorphisms in the promoter region of the human BMAL1 gene that are associated 
with hypertension [7]. Mice with targeted disruption of any of the positive or negative 
elements of the circadian clock based on the transcriptional feedback loop display either 
decreased or increased blood pressure (reviewed in [2,23]). Recent studies have begun to shed 
light on the possible role of the kidney in these dysfunctions. As mentioned above, a great 
number of renal mRNA transcripts exhibit circadian expression pattern. However, only a few 
proteins have been experimentally shown to undergo circadian oscillations.  For instance, 
Saifur Rohman et al. have shown that mRNA and protein expression of sodium-proton 
exchanger 3 (NHE3) displays a circadian expression pattern which was blunted in 
CRY1/CRY2 double knockout mice [24]. Recently, Susa et al. have demonstrated that 
proteins involved in renal sodium homeostasis and blood pressure control can be modified in 
a circadian manner on the posttranslational level [**25]. By analyzing WNK-OSR1/SPAK-
NCC signaling cascade they were able to show that the phosphorylation level of OSR1 and 
SPAK kinases as well as the sodium-chloride co-transporter (NCC) display significant 
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circadian oscillation with the peak of phosphorylation at the time of transition between the 
inactive and active phases of the circadian cycle. The authors also demonstrate that this 
rhythmicity in phosphorylation state is driven by aldosterone and they interpreted the 
circadian phosphorylation kinetic of the cascade as a requirement to decrease sodium 
reabsorption during the active phase and to increase during the rest phase. 
Aldosterone is the major regulator of sodium balance and blood pressure. Doi et al. 
have shown that secretion of this mineralocorticoid hormone by the adrenal glands is 
controlled by the circadian clock [26]. The authors demonstrated that beta-hydroxyl-steroid 
dehydrogenase (Hsd3b6), a steroidogenic enzyme involved in aldosterone biosynthesis, is 
transcriptionally regulated by the molecular clock. In Cry1/Cry2 double knockout mice that 
exhibit constantly elevated activity of the circadian clock, the plasma aldosterone levels are 
markedly increased causing salt-sensitive hypertension. Gumz and colleagues have shown 
that aldosterone can influence sodium reabsorption in the distal nephron and the collecting 
duct by interfering with the circadian clock activity. They demonstrated that aldosterone 
upregulates the expression level of the alpha subunit of the epithelial sodium channel 
(αENaC) in part through the stimulation of Per1 expression [27,28]. This finding was recently 
supported and extended by Richards et al. who demonstrated that αENaC expression and 
ENaC activity are significantly reduced upon inhibition of casein kinases 1δ and 1ε (CK1δ/ε) 
which are required for the phosphorylation and nuclear localization of PER/CRY 
heterodimers [*29]. The same group has recently reported that Per1 knockout mice exhibit 
low blood pressure [12]. 
Recently, we have shown that mice devoid of CLOCK exhibit dramatic changes in the 
circadian dynamic of urinary sodium, potassium and water excretion [**11]. Further 
functional analysis revealed that suppression of CLOCK abolishes the normal circadian 
rhythmicity of plasma aldosterone levels and results in a significant reduction in blood 
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pressure. Importantly, all these changes occurred despite normal pattern of physical activity 
and water intake in the knockout mice. To identify molecular mechanism underlying these 
dysfunctions we analyzed transcriptional changes in kidneys of these mice. Interestingly, the 
most significant difference was observed in the expression levels of cytochrome-P450 
enzymes (Cyp4a12 and Cyp4a14) involved in the oxidation of arachidonic acid to 20-
Hydroxyeicosatetraenoic acid (20-HETE). Analysis of temporal changes in 20-HETE levels 
in the kidney revealed a circadian-like pattern that was significantly modified in the knockout 
mice. 20-HETE has been shown to have a complex influence on blood pressure by inducing 
vasoconstriction and by inhibiting sodium reabsorption in the renal tubule. Collectively, this 
study suggested that the Cyp4a/20-HETE pathway could be one of the regulatory mechanisms 
by which the circadian clock participates in blood pressure control.  
The circadian clock and human diseases.  Given the pivotal role of the circadian clock in a 
variety of cellular functions, numerous studies have addressed the role of the circadian clock 
genes in pathogenesis of human diseases. Different animal models have been created and/or 
used to evaluate this issue. One of the most striking finding was obtained in the model of 
golden hamster heterozygous for a loos-of-function mutation in the circadian regulatory gene 
casein kinase-1epsilon [30]. These animals exhibit extensive fibrosis leading to 
cardiomyopathy, renal insufficiency and premature death when exposed to the light-dark 
cycles longer than the period of their intrinsic circadian clock, while the same animals kept in 
the light-dark cycle synchronized with their intrinsic circadian clock do perfectly well [31]. 
Another example is given by mice devoid of the three clock output genes DBP-HLF-TEF 
which display lower blood pressure, lower aldosterone levels and cardiac hypertrophy [32]. 
In humans, evidence showing a link between the circadian clock and diseases is 
weaker and more indirect. Unbiased genome-wide association studies (GWAS) have 
associated single nucleotide polymorphisms in loci close to genes involved in the molecular 
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clock with several traits. When searched in the catalog of published GWAS 
(http://www.genome.gov/gwastudies/), we found that rs900145, close to BMAL1 (ARNTL), 
was associated with age at menarche [33] and plasminogen activator inhibitor-1 (PAI-1) 
plasma levels [34], and that the CRY2 variant rs11605924 was associated with fasting glucose 
levels and beta cell function [6,35]. Moreover, a CLOCK variant was associated with 
agreeableness in one study [8] and NPAS2 with a variant form of Creutzfeldt-Jakob disease in 
another study [36]. The PER1, PER2, CRY1, DBP, TEF and HLF or other genes coding for 
important components of the molecular clock have not display any significant association in 
GWAS conducted so far. In order to establish causality, one would need to study human 
beings with proven and unique deletion or mutation leading to significant disruption of the 
circadian clock. The only Mendelian disease known to be associated with the circadian clock 
is the autosomal dominant familial advanced sleep-phase syndrome (OMIM 604348) in which 
the genes PER2 and CSNK1D are mutated [37-39]. However, these families are extremely 
rare, poorly characterized and no data on their long-term health status is available. Another 
rare syndrome recently associated with the circadian clock function is the Smith-Magenis 
syndrome in which haploinsufficiency of RAI1 gene leads to a complex clinical phenotype 
characterized by low intellectual capabilities, sleep-disorders disturbances, obesity and 
various neurobehavioral and congenital anomalies. One of the hallmarks of this syndrome is 
an inverted melatonin rhythm that leads, as a consequence, to diurnal somnolence and 
nocturnal sleep difficulties. RAI1 was shown to be an important regulator of the expression of 
CLOCK and other components of the clock system [40].  
One of the most prominent circadian traits in human is blood pressure. Nocturnal dip 
of blood pressure is a well-known phenomenon, but the underlying physiological 
mechanism(s) still remains largely elusive. Numerous studies have attempted to address the 
role of the circadian clock in this phenomenon in shiftworkers [41-44]. These studies, 
 10 
however, have yielded in conflicting results. In total, evidence establishing causality between 
shiftwork and hypertension are scarce and do not allow definitive conclusion. 
 
Chronotherapy for hypertension? Accumulating evidence suggests that the 
antihypertensive medication should be preferentially taken at vesper time. Using HYGIA 
cross-sectional data and MAPEC prospective data, Hermida and colleagues showed that 
prescription of at least one anti-hypertensive drug at bedtime controlled hypertension 
significantly better than when taking the treatment exclusively in the morning [45]. These and 
other data were recently reviewed in a meta-analysis of 21 studies that included ~2000 
patients suffering from primary hypertension [46]. Evening taking of antihypertensive drugs 
was associated with a significantly better control of 24 hour blood pressure than morning 
dosing (SBP: -1.71 mm Hg, 95% CI: -2.78 to -0.65; DBP: -1.38 mm Hg, 95% CI: -2.13 to -
0.62), but the clinical relevance and the effect on harder endpoints such as cardiovascular 
events remains unexplored. The mechanisms by which this effect would take place are still 
speculative. Pharmacokinetics and/or pharmacodynamics profiles for a given drug might be 
more optimal in the evening, even though almost any kind of antihypertensive drug tested so 
far has shown better effect when taken in the evening. This suggests a more general, drug-
independent mechanism. 
 
Conclusions 
Identification of the molecular components of the clock system has allowed significant 
advances in the comprehension of circadian rhythms at the transcriptional level, and has 
brought forward new mechanisms of regulation e.g. at translational level or by redox reaction. 
The renal and hypertension fields start to benefit from these progresses. In particular, 
circadian rhythms should be taken into account in daily interpretation of data collected at 
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different times of the day. Research should be oriented at deciphering circadian rhythms of 
complex traits i.e. traits in which several levels of circadian-dependent regulation are taking 
place. Chronotherapeutics may help ameliorating the control of blood pressure in humans and 
open new perspective in other fields.  
 
Figure legend.  
Figure 1. Circadian expression patterns of mRNAs encoding different amino acid (AA) 
transporters in the mouse proximal tubule. Y-axis is the expression level in arbitrary units. ZT 
- Zeitgeber time units: ZT0 is the time of light on and ZT12 is the time of light off. 
Figure 2. Different origin of circadian rhythms in the kidney. The circadian rhythmicity in 
filtered loads results from the circadian rhythms in the GFR, the RBF and the circadian 
oscillations in blood levels of filtered compounds. The circadian rhythms in urinary excretion 
is the sum of circadian rhythms in filtered loads and tubular reabsorption/secretion. Of note, 
the period length of these functional rhythms is approximately the same (~ 24 hours), but the 
difference between their maximum and minimum values (amplitude) as well as the time of the 
day when the given process function at a maximal rate (acrophase) can vary considerably. 
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